The clinical management of hepatocellular carcinoma in China: Progress and challenges

키워드

참고문헌 (24)

1. "Data visualization tools for exploring the global cancer burden in 2020"[URL]
2. Takuji Torimura, "Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects", Clinical and Molecular Hepatology, 27(2), pp.236~245 (2021), 대한간학회[DOI]
3. Dhanasekaran R, "Genomic medicine and implications for hepatocellular carcinoma prevention and therapy", Gastroenterology, 156, pp.492~509 (2019)
4. Liu Z, "Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China", Cancer Med, 8, pp.5787~5799 (2019)
5. Qu C, "Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study : a cluster randomized controlled trial", PLoS Med, 11, pp.e1001774~ (2014)
6. Yang B, "Prospective study of early detection for primary liver cancer", J Cancer Res Clin Oncol, 123, pp.357~360 (1997)
7. Zhang BH, "Randomized controlled trial of screening for hepatocellular carcinoma", J Cancer Res Clin Oncol, 130, pp.417~422 (2004)
8. Xu RH, "Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma", Nat Mater, 16, pp.1155~1161 (2017)
9. Wei X, "Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus : A randomized, open-label, multicenter controlled study", J Clin Oncol, 37, pp.2141~2151 (2019)
10. Shao G, "Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib(REACH-2 China) : A randomised, multicentre, doubleblind study", EClinicalMedicine, 54, pp.101679~ (2022)
11. Diyang Xie, "Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective", Clinical and Molecular Hepatology, 29(2), pp.206~216 (2023), 대한간학회
12. Yu S, "Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019 : An age-period-cohort analysis", Sci Prog, 104, pp.368504211018081~ (2021)
13. Li M, "Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China", Lancet Reg Health West Pac, 16, pp.100249~ (2021)
14. Cui F, "Global reporting of progress towards elimination of hepatitis B and hepatitis C", Lancet Gastroenterol Hepatol, 8(4), pp.332~342 (2023)
15. Ji M, "Mass screening for liver cancer : results from a demonstration screening project in Zhongshan City, China", Sci Rep, 8, pp.12787~ (2018)
16. Lin J, "Epidemiological characteristics of primary liver cancer in mainland China from 2003 to 2020 : A representative multicenter study", Front Oncol, 12, pp.906778~ (2022)
17. Wu J, "Disparities in hepatocellular carcinoma survival by insurance status : A population-based study in China", Front Public Health, 9, pp.742355~ (2021)
18. Prevention of Infection Related Cancer (PIRCA) Group, "Strategies of primary prevention of liver cancer in China: expert consensus (2018)", Zhonghua Yu Fang Yi Xue Za Zhi, 53, pp.36~44 (2019)
19. Nan Y, "Consensus on the secondary prevention of primary liver cancer", Hepatol Int, 15, pp.1289~1300 (2021)
20. Chinese Society of Hepatology, "The consensus on tertiary prevention of primary liver cancer (2022 version)", Zhonghua Gan Zang Bing Za Zhi, 30, pp.832~845 (2022)
21. Liu Z, "Management algorithm for prevention of mother-to-child transmission of hepatitis B virus(2022)", J Clin Transl Hepatol, 10, pp.1004~1010 (2022)
22. Li J, "A study protocol of population-based cancer screening cohort study on esophageal, stomach and liver cancer in rural China", Chin J Cancer Res, 32, pp.540~546 (2020)
23. Won Sohn, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clinical and Molecular Hepatology, 28(4), pp.851~863 (2022), 대한간학회
24. Jung Hwan Yu, "The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection", Clinical and Molecular Hepatology, 28(3), pp.351~361 (2022), 대한간학회[DOI]

관련 논문AI추천